TPST

NASDAQStock

Tempest Therapeutics, Inc.

$2.22-0.07 (-3.06%)

52-Week Range

$1.27

$5.92

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

-2.18

Volume

40.2K

Avg Volume

107.1K

Performance

-0.87%

+55.78%

-53.83%

YTD

+55.25%

-58.04%

-72.04%

-96.86%

Price Chart

ETF Exposure

TPST is held by 9 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
DCOR	Dimensional - US Core Equity 1 ETF	0.00%	3,985	$9K	$2.68B	0.14%
DFAC	Dimensional - US Core Equity 2 ETF	0.00%	107	$245	$40.55B	0.17%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	5	$19	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	184	$678	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	0	$3	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	104,944	$285K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	551	$2K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	47	$175	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	35,200	$96K	$84.10B	0.05%

About TPST ETF Exposure

Tempest Therapeutics, Inc. (TPST) is held by 9 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $2.22. Investors can gain exposure to TPST through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TPST, sorted by portfolio weight.